16 Aug 2012 11:29
ORYX INTERNATIONAL GROWTH FUND LIMITED
Β INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012
Β Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.
Β This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.
Β This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.
Β Manager's Review
During the period under review, the FTSE Small Cap TR (Β£) Index returned -4.24% and the FTSE All-Share TR Index (Β£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.
Β The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.
Β Material Transactions
Since 1 April 2012, the Company has purchased for cancellation the following shares:
Β 24 April 2012 a total of 379,653 ordinary shares at a gross price of Β£2.10 per share.
Material Events
There were no material events during the quarter ended 30 June 2012.
Β Report and Accounts
On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.
Financial Highlights
Β
Β | 30 June 2012Β | 31 MarchΒ 2012Β | 31 DecemberΒ 2011Β | 30 SeptemberΒ 2011Β | 30 JuneΒ 2011Β |
Β | Β | Β | Β | Β | Β |
NAV | Β£2.93 | Β£3.03 | Β£2.79 | Β£2.69 | Β£2.96 |
Β | Β | Β | Β | Β | Β |
US Dollar / Sterling Exchange Rate | Β 1.5685 | Β 1.5978 | Β 1.5541 | Β 1.5579 | Β 1.6055 |
Β | Β | Β | Β | Β | Β |
Β
Β
Twenty Largest Equity Investments at 30 June 2012
Β
% Net Assets | ||
Cvs Group Plc | 7.85 | |
Bioquell Plc | 6.84 | |
Gleeson (M.J.) Group Plc | 6.67 | |
Guinness Peat Group Plc | 6.36 | |
Orthoproducts Ltd | 4.99 | |
Augean Plc | 4.96 | |
Journey Group Plc | 4.29 | |
Eckoh Plc | 4.28 | |
Quarto Group Inc | 4.26 | |
Catalyst Media Group Plc | 4.14 | |
Assetco Plc | 3.80 | |
Innovation Group Plc | 3.76 | |
Sinclair Is Pharma Plc | 3.23 | |
Rpc Group Plc | 2.75 | |
Nastor Inv Ltd Zero Redeem Prefer Shares | 2.61 | |
Mecom Group Plc | 2.42 | |
Bionostics Holdings Ltd | 2.40 | |
Celsis Ag | 2.09 | |
Bavaria Industriekapital Ag | 2.09 | |
Sinav Limited | 1.99 | |
|
Β
Β
The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.
Β
By order of the Board
Β
BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of
Oryx International Growth Fund Limited
as Company Secretary
Follow the stocks